Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 294 publications
Convergence of Local and Systemic Therapies: A Comprehensive Society of Interventional Oncology Framework for 90Y Radioembolization with Immunotherapy in HCC.
Journal: Radiology
Published: September 01, 2026
A multicenter pilot study of nivolumab with drug-eluting bead transarterial chemoembolization in patients with liver-limited hepatocellular carcinoma.
Journal: ESMO gastrointestinal oncology
Published: August 28, 2026
Evaluating the Prognostic Impact of IDH Mutations in Intrahepatic Cholangiocarcinoma.
Journal: JCO precision oncology
Published: August 04, 2026
ASO Visual Abstract: Investigating Age-Related Differences in Survival Outcomes and Mutation Status in Patients with Intrahepatic Cholangiocarcinoma.
Journal: Annals of surgical oncology
Published: July 25, 2026
Clinical and LAT1 Biomarker Correlates of Clinical Benefit from Nanvuranlat (JPH203) in Advanced Biliary Tract Cancer: A Post Hoc Analysis.
Journal: Cancers
Published: July 02, 2026
Investigating Age-Related Differences in Survival Outcomes and Mutation Status of Patients with Intrahepatic Cholangiocarcinoma.
Journal: Annals of surgical oncology
Published: May 22, 2026
Plain language summary of five-year overall survival update from the HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma (liver cancer).
Journal: Future oncology (London, England)
Published: May 11, 2026
Durvalumab and tremelimumab, with or without lenvatinib, combined with transarterial chemoembolisation in participants with embolisation-eligible hepatocellular carcinoma (EMERALD-3): a global, randomised, open-label, sponsor-blinded, phase 3 study.
Journal: The Lancet. Oncology
Published: May 08, 2026
Extended Follow-Up of Botensilimab Plus Balstilimab in an Expanded Cohort of Microsatellite-Stable Metastatic Colorectal Cancer Without Active Liver Metastases.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 01, 2026
Radiology considerations for the PREMIUM study: a multicenter randomized controlled trial of abbreviated MRI versus ultrasound for liver cancer screening in cirrhosis.
Journal: Abdominal radiology (New York)
Published: April 27, 2026
Quantitative benefit-risk assessment of data from the phase III ClarIDHy study of ivosidenib versus placebo in patients with mIDH1 cholangiocarcinoma.
Journal: ESMO gastrointestinal oncology
Published: February 06, 2026
Molecular and Clinical Determinants of Targeted Therapy Treatment in Biliary Tract Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 29, 2026
Last Updated: 09/26/2026